Biopharma News
AskBio initiates recruitment to its Phase 2 Parkinson’s Disease trial
AskBio a gene therapy company wholly owned and independently operated as a subsidiary of Bayer, has announced initiation of recruitment to REGENERATE-PD, a Phase 2 clinical study assessing efficacy and safety of AB-1005. Read more
26 Jun 2024
Sage Therapeutics to Implement a 40% Workforce Reduction
Sage Therapeutics, Inc announced late last week plans to reorganise its business operations and pipeline priorities to support goals for long-term business growth. Read more
4 Sep 2023
IO Biotech Appoints Heidi Hunter to its Board of Directors
IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win technology platform, announced the appointment of Heidi Hunter to its board of directors. Read more
11 Aug 2023
Lytix Biopharma’s Licensing Partner Verrica Pharmaceuticals Reports Interim Phase 2 Data With LTX-315
Lytix Biopharma announces that its licensing partner Verrica Pharmaceuticals Inc has reported lesion clearance data from Part 1 of an ongoing Phase 2 study of VP-315 (formerly known as LTX 315) for the treatment of basal cell carcinoma (BCC). Read more
11 Aug 2023
Kincell Bio Launches with $36M to Make Cell Therapy Development and Manufacturing Accessible for Early-Stage Innovators
Kincell Bio, a technology-forward contract development and manufacturing organisation (CDMO) focused on cell therapies, emerged from stealth with $36 million in new funding. Read more
7 Aug 2023
AstraZeneca appoints Sharon Barr as Executive Vice President BioPharmaceuticals R&D
AstraZeneca today announced the appointment of Sharon Barr as Executive Vice President, BioPharmaceuticals R&D. Read more
4 Aug 2023
Leqembi, Donanemab and Tofersen: The End of the Journey or the First Step on the Road to Reversing Neurodegeneration?
Dr. Peter Hamley, Chief Scientific Officer at Samsara Therapeutics, explores whether developments in therapeutics for neurodegenerative diseases are truly disease modifying or addressing the symptoms of a deeper problem. Read more
16 Aug 2023
R&D revolution: A new paradigm of sourcing and landscaping for the pharma industry
Dr Robin Knight, Co-Founder & Co-CEO of IN-PART, discusses the emerging importance of outsourcing landscaping activities within the pharmaceuticals industry and the benefits of adopting an openly innovative approach that pools sources of innovation. Read more
12 Jul 2023
Enhancing Biotherapeutic Properties with Cell-Line Engineering
Neha Mishra, Ph.D, Senior Scientist Bioproduction at Revvity explores enhancing biotherapeutic properties with cell-line engineering. Read more
30 Jun 2023
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
CARBOGEN AMCIS Passes Two FDA Inspections at its Manufacturing Sites in Switzerland
Both sites in Neuland and Aarau passed the inspection processes with No Actions Indicated (NAIs) identified. Read more
26 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Finish Thompson highlights drum pumps for pharma applications
Finish Thompson Inc. (FTI), a specialist in the corrosive chemical transfer industry, highlights its SFV drum pump, a cost-effective pump designed for container-to-container transfer of acids, corrosives, and chemicals. Read more
26 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
LYVA Labs' Innovate UK Biomedical Catalyst Microbials Accelerator companies secure £857,000 in funding
Nine innovative businesses have received receiving £857k in funding, from the Innovate UK Biomedical Catalyst feasibility grant, after completing LYVA Labs’ Microbials Accelerator programme - the first Innovate UK programme of its kind in this field. Read more
25 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Broken String Biosciences Appoints New Chief Commercial Officer
The newly appointed Steve Becker will help guide the genomics company as it expands its commercial operations. Read more
25 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sirnaomics announces completion of IND-Enabling studies of safety and efficacy for STP125G with NHP models
Sirnaomics, a leading biopharmaceutical company engaging in the discovery and development of advanced RNAi therapeutics, announced today that it has completed IND-enabling studies for STP125G. Read more
24 Jul 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Enterprise Therapeutics Doses First Person with Cystic Fibrosis with ETD001
As part of the Phase 2a trial, ETD001 aims to clear mucus and increase hydration by targeting the epithelial sodium channel. Read more
24 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News